Meiying Chang
Overview
Explore the profile of Meiying Chang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang M, Shi X, Yang B, Li P, Zhang Y, Zhang Q, et al.
Ren Fail
. 2025 Feb;
47(1):2459896.
PMID: 39972601
Objective: This study aims to investigate the therapeutic effects of modified Huangqi Chifeng decoction (MHCD) on proteinuria in membranous nephropathy (MN) and its potential protective effects on podocytes. Furthermore, we...
2.
Chang M, Li Q, Shi Z, Zhuang S
Clin Pharmacol Ther
. 2025 Feb;
PMID: 39907556
Aurora kinases are a family of serine/threonine kinases that includes Aurora kinase A, Aurora kinase B, and Aurora kinase C. These kinases play crucial roles in mitotic spindle formation and...
3.
Zhao M, Yin Y, Yang B, Chang M, Ma S, Shi X, et al.
J Ethnopharmacol
. 2023 Dec;
321:117520.
PMID: 38042389
Ethnopharmacological Relevance: Proteinuria is recognized as a risk factor for the exacerbation of chronic kidney disease. Modified Huangqi Chifeng decoction (MHCD) has distinct advantages in reducing proteinuria. Our previous experimental...
4.
Chang M, Shi X, Ma S, Zhao M, Fan J, Pan Z, et al.
Eur J Pharmacol
. 2023 Nov;
961:176198.
PMID: 37972847
The pathogenesis of immunoglobulin A nephropathy (IgAN) is closely related to immunity and inflammation. The clinical process of IgAN varies greatly, making the assessment of prognosis challenging and limiting progress...
5.
Shi X, Zhang Q, Chang M, Zhang Y, Zhao M, Yang B, et al.
Heliyon
. 2023 Oct;
9(10):e21050.
PMID: 37886789
Ferroptosis is found to be involved in some experimental models of kidney diseases, but its role in membrane nephropathy (MN) is still unclear. The purpose of this study is to...
6.
Ma S, Zhao M, Chang M, Shi X, Shi Y, Zhang Y
Phytomedicine
. 2023 Jun;
117:154913.
PMID: 37307737
Background: Immunoglobulin A nephropathy (IgAN), is the main cause of end-stage renal disease, that causes serious physical and psychological burden to patients worldwide. Some traditional treatment measures, such as blocking...
7.
Li Q, Chang M, Lai R, Zhang H, Song L, Wang X, et al.
Nutrition
. 2023 May;
112:112062.
PMID: 37236043
Objectives: Dietary capsaicin from spicy foods has potential benefits for those with cardiometabolic diseases (CMDs). However, to our knowledge there is no evidence linking spicy food consumption with cardiovascular outcomes...
8.
Shi Y, Shi X, Zhao M, Chang M, Ma S, Zhang Y
Biomed Pharmacother
. 2023 May;
163:114849.
PMID: 37172334
Acute kidney injury (AKI) is a major health concern owing to its high morbidity and mortality rates, to which there are no drugs or treatment methods, except for renal replacement...
9.
Zhao M, Zhang Z, Pan Z, Ma S, Chang M, Fan J, et al.
Pharmaceuticals (Basel)
. 2023 Mar;
16(3).
PMID: 36986438
Renin-angiotensin system (RAS) inhibitors and calcium channel blockers (CCB) are often used together in chronic kidney disease (CKD). The PubMed, EMBASE, and Cochrane Library databases were searched to identify randomized...
10.
Pan Z, Zhao M, Chang M, Shi X, Ma S, Zhang Y
Medicine (Baltimore)
. 2023 Mar;
102(10):e33123.
PMID: 36897707
Background: IgA nephropathy (IgAN) is a common primary glomerular disease, and supplementing qi dispelling wind and activating blood is commonly used as a treatment method in Chinese medicine. However, the...